Satoshi Anai Selected Research

NADPH Oxidases (NAD(P)H oxidase)

10/2012	ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.
10/2011	ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Anai Research Topics

Disease

51	Neoplasms (Cancer) 01/2023 - 02/2003
47	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 04/2006
22	Carcinoma (Carcinomatosis) 01/2022 - 02/2003
20	Urinary Bladder Neoplasms (Bladder Cancer) 06/2021 - 04/2009
18	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 02/2003
10	Non-Muscle Invasive Bladder Neoplasms 07/2022 - 01/2010
7	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2011
7	Lower Urinary Tract Symptoms 01/2022 - 12/2014
6	Adenocarcinoma 12/2020 - 05/2007
4	Margins of Excision 10/2019 - 11/2007
3	Hypertension (High Blood Pressure) 01/2024 - 02/2016
3	Chronic Renal Insufficiency 11/2023 - 03/2014
3	Urologic Neoplasms (Urological Cancer) 04/2022 - 05/2020
3	Infections 08/2021 - 01/2019
3	Carcinogenesis 12/2020 - 03/2010
3	Inflammation (Inflammations) 05/2019 - 01/2017
2	Pathologic Constriction (Stenosis) 01/2024 - 01/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2023 - 05/2018
2	Hemorrhage 03/2023 - 01/2021
2	Pneumonia (Pneumonitis) 03/2023 - 08/2015
2	Sarcopenia 07/2022 - 05/2020
2	Hypoxia (Hypoxemia) 01/2022 - 03/2011
2	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 08/2017
2	Pain (Aches) 01/2021 - 05/2020
2	Body Weight (Weight, Body) 07/2020 - 09/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 01/2018
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2019 - 05/2018
2	Adenocarcinoma of Lung 01/2018 - 10/2016
2	Carcinoma in Situ 10/2016 - 04/2009
1	Consciousness Disorders 01/2024
1	Atrial Fibrillation 01/2024
1	Eosinophilia 03/2023
1	Respiratory Insufficiency (Respiratory Failure) 03/2023
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 03/2023
1	Nocturia 07/2022

Drug/Important Bio-Agent (IBA)

11	AcidsIBA 01/2022 - 05/2014
11	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 04/2006
11	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2005
8	Sunitinib (Sutent)FDA Link 05/2023 - 06/2012
7	Axitinib (AG 013736)IBA 11/2023 - 10/2018
7	Small Interfering RNA (siRNA)IBA 05/2020 - 04/2009
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 10/2007
6	AndrogensIBA 02/2022 - 08/2007
5	pembrolizumabIBA 01/2023 - 05/2020
5	Gemcitabine FDA Link 01/2022 - 06/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2009
4	protoporphyrin IXIBA 01/2022 - 08/2014
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2017
4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2020 - 05/2011
4	Heme Oxygenase-1IBA 03/2016 - 01/2010
3	CytokinesIBA 05/2023 - 04/2019
3	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2019 - 12/2014
3	Biomarkers (Surrogate Marker)IBA 11/2017 - 05/2014
2	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 03/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2023 - 08/2021
2	Testosterone (Sustanon)FDA Link 02/2022 - 01/2020
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2012
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 03/2016
2	PlatinumIBA 01/2022 - 12/2018
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2022 - 09/2020
2	silodosin FDA Link 11/2021 - 12/2014
2	naftopidilIBA 11/2021 - 12/2014
2	NitrosaminesIBA 06/2021 - 05/2020
2	Syndecan-1 (Syndecan 1)IBA 05/2020 - 12/2013
2	Docetaxel (Taxotere)FDA Link 01/2020 - 12/2019
2	AntibodiesIBA 04/2019 - 01/2019
2	Iodine-125IBA 01/2019 - 08/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 10/2017
2	Monoclonal AntibodiesIBA 01/2019 - 07/2005
2	Flutamide (Eulexin)FDA LinkGeneric 05/2018 - 08/2015
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 03/2010
2	CollagenIBA 11/2017 - 05/2017
2	Everolimus FDA Link 01/2017 - 08/2015
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 06/2012
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2012 - 10/2011
2	Phosphotransferases (Kinase)IBA 06/2012 - 04/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2011 - 05/2007
2	zinc protoporphyrinIBA 03/2011 - 06/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2010 - 09/2008
2	Green Fluorescent ProteinsIBA 04/2009 - 09/2008
2	OligodeoxyribonucleotidesIBA 07/2007 - 01/2007
1	Amiodarone (Amiodarona)FDA LinkGeneric 03/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023
1	HemosiderinIBA 03/2023
1	lenvatinibIBA 01/2023

Therapy/Procedure

33	Therapeutics 11/2023 - 02/2003
19	Brachytherapy 01/2023 - 09/2012
13	Radiotherapy 01/2022 - 10/2006
11	Drug Therapy (Chemotherapy) 01/2022 - 01/2007
10	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 05/2007
9	Nephrectomy 08/2021 - 02/2003
6	Cystectomy 10/2019 - 01/2016
5	Transurethral Resection of Bladder 02/2021 - 03/2016
4	Castration 07/2022 - 04/2014
3	Nephroureterectomy 01/2021 - 05/2019
2	Molecular Targeted Therapy 05/2023 - 10/2018
2	Oral Administration 06/2021 - 06/2015
2	Operative Time 01/2021 - 02/2019
2	Neoadjuvant Therapy 10/2019 - 04/2018
1	Catheters 01/2024